GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » ROE % Adjusted to Book Value

Tatva Chintan Pharma Chem (BOM:543321) ROE % Adjusted to Book Value : 1.52% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem ROE % Adjusted to Book Value?

Tatva Chintan Pharma Chem's ROE % for the quarter that ended in Mar. 2024 was 5.22%. Tatva Chintan Pharma Chem's PB Ratio for the quarter that ended in Mar. 2024 was 3.43. Tatva Chintan Pharma Chem's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 1.52%.


Tatva Chintan Pharma Chem ROE % Adjusted to Book Value Historical Data

The historical data trend for Tatva Chintan Pharma Chem's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem ROE % Adjusted to Book Value Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - 2.78 1.28 1.41

Tatva Chintan Pharma Chem Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 - 0.84 - 1.52

Competitive Comparison of Tatva Chintan Pharma Chem's ROE % Adjusted to Book Value

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem's ROE % Adjusted to Book Value Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's ROE % Adjusted to Book Value falls into.



Tatva Chintan Pharma Chem ROE % Adjusted to Book Value Calculation

Tatva Chintan Pharma Chem's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.85% / 3.43
=1.41%

Tatva Chintan Pharma Chem's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.22% / 3.43
=1.52%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tatva Chintan Pharma Chem ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem (BOM:543321) Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines